Inactive Instrument

VERA PHARADR Stock Nasdaq

Equities

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Verona Pharma Initiates U.S. Clinical Pharmacokinetic Study for RPL554 Following Acceptance of IND Application by FDA	17-06-05	GL
Verona Pharma to Present at Jefferies 2017 Global Healthcare Conference	17-05-23	GL
Verona Pharma Announces Closing of Exercise of Underwriters’ Over-allotment Option	17-05-18	GL
Grant of Options and RSUs and PDMR Dealings	17-05-03	GL
Verona Pharma Announces Closing of Global Offering	17-05-02	GL

Sector